Bertrand Knebelmann

12.9k total citations · 2 hit papers
123 papers, 6.2k citations indexed

About

Bertrand Knebelmann is a scholar working on Molecular Biology, Genetics and Nephrology. According to data from OpenAlex, Bertrand Knebelmann has authored 123 papers receiving a total of 6.2k indexed citations (citations by other indexed papers that have themselves been cited), including 56 papers in Molecular Biology, 39 papers in Genetics and 34 papers in Nephrology. Recurrent topics in Bertrand Knebelmann's work include Renal Diseases and Glomerulopathies (26 papers), Genetic and Kidney Cyst Diseases (22 papers) and Renal and related cancers (18 papers). Bertrand Knebelmann is often cited by papers focused on Renal Diseases and Glomerulopathies (26 papers), Genetic and Kidney Cyst Diseases (22 papers) and Renal and related cancers (18 papers). Bertrand Knebelmann collaborates with scholars based in France, United States and United Kingdom. Bertrand Knebelmann's co-authors include Vikas P. Sukhatme, Corinne Antignac, Mohanraj Dhanabal, Hua Lu, Matthew J.F. Waterman, Ramani Ramchandran, Mark S. Segal, Herbert T. Cohen, Fádi Fakhouri and Laurence Heidet and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Bertrand Knebelmann

113 papers receiving 6.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Endostatin Induces Endothelial Cell Apoptosis

1999 502 citations Bertrand Knebelmann et al. profile →
Inaxaplin for Proteinuric Kidney Disease in Persons with Two APOL1 Variants

2023 98 citations Bertrand Knebelmann et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bertrand Knebelmann France	46	3.0k	1.7k	1.3k	1.0k	890	123	6.2k
Peter L. Weissberg United Kingdom	52	4.2k 1.4×	2.5k 1.5×	1.3k 1.0×	2.1k 2.0×	570 0.6×	119	11.4k
Yohei Maeshima Japan	36	3.0k 1.0×	1.3k 0.8×	364 0.3×	609 0.6×	1.1k 1.3×	94	5.6k
Jeffrey W. Pippin United States	52	3.5k 1.1×	4.5k 2.7×	1.2k 1.0×	764 0.7×	243 0.3×	130	7.8k
Jan A. Bruijn Netherlands	44	1.8k 0.6×	4.1k 2.5×	649 0.5×	2.8k 2.8×	497 0.6×	159	8.6k
Sean Morony United States	27	6.4k 2.1×	639 0.4×	815 0.6×	411 0.4×	277 0.3×	40	9.0k
Ildiko Sarosi United States	22	5.5k 1.8×	497 0.3×	661 0.5×	510 0.5×	288 0.3×	30	8.8k
Marie-Claire Gübler France	60	5.3k 1.7×	4.6k 2.8×	2.6k 2.0×	1.5k 1.5×	1.7k 1.9×	256	11.8k
Jun‐ichi Hanai United States	30	4.0k 1.3×	590 0.4×	446 0.3×	632 0.6×	211 0.2×	40	6.9k
Marcus J. Moeller Germany	42	2.3k 0.8×	2.9k 1.7×	725 0.6×	541 0.5×	258 0.3×	97	5.0k
Elisabeth M. Zeisberg Germany	28	3.8k 1.2×	878 0.5×	386 0.3×	1.1k 1.1×	212 0.2×	57	7.0k

Countries citing papers authored by Bertrand Knebelmann

Since Specialization

Citations

This map shows the geographic impact of Bertrand Knebelmann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bertrand Knebelmann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bertrand Knebelmann more than expected).

Fields of papers citing papers by Bertrand Knebelmann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bertrand Knebelmann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bertrand Knebelmann. The network helps show where Bertrand Knebelmann may publish in the future.

Co-authorship network of co-authors of Bertrand Knebelmann

This figure shows the co-authorship network connecting the top 25 collaborators of Bertrand Knebelmann. A scholar is included among the top collaborators of Bertrand Knebelmann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bertrand Knebelmann. Bertrand Knebelmann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sens, Florence, Laure Guittard, Bertrand Knebelmann, et al.. (2024). Prevalence of Fabry Disease in Patients on Dialysis in France. International Journal of Molecular Sciences. 25(18). 10104–10104.

Gansevoort, Ronald T., Ali Hariri, Pascal Minini, et al.. (2022). Venglustat, a Novel Glucosylceramide Synthase Inhibitor, in Patients at Risk of Rapidly Progressing ADPKD: Primary Results of a Double-Blind, Placebo-Controlled, Phase 2/3 Randomized Clinical Trial. American Journal of Kidney Diseases. 81(5). 517–527.e1. 12 indexed citations

Perrone, Ronald D., Ali Hariri, Pascal Minini, et al.. (2022). The STAGED-PKD 2-Stage Adaptive Study With a Patient Enrichment Strategy and Treatment Effect Modeling for Improved Study Design Efficiency in Patients With ADPKD. Kidney Medicine. 4(10). 100538–100538. 7 indexed citations

Bertholet‐Thomas, Aurélia, Maria A. Manso-Silván, Véronique Baudouin, et al.. (2021). Safety, efficacy, and acceptability of ADV7103 during 24 months of treatment: an open-label study in pediatric and adult patients with distal renal tubular acidosis. Pediatric Nephrology. 36(7). 1765–1774. 11 indexed citations

Germain, Dominique P., Thierry Levade, Bertrand Knebelmann, et al.. (2021). Challenging the traditional approach for interpreting genetic variants: Lessons from Fabry disease. Clinical Genetics. 101(4). 390–402. 46 indexed citations

Servais, Aude, Kay Thomas, Luca Dello Strologo, et al.. (2020). Cystinuria: clinical practice recommendation. Kidney International. 99(1). 48–58. 65 indexed citations

Knebelmann, Bertrand, David Buob, Marion Rabant, et al.. (2020). AA amyloidosis associated with Fabry disease. International Journal of Clinical Practice. 74(10). e13577–e13577. 1 indexed citations

Faviez, Carole, Xiaoyi Chen, Nicolas Garcelon, et al.. (2020). Diagnosis support systems for rare diseases: a scoping review. Orphanet Journal of Rare Diseases. 15(1). 94–94. 56 indexed citations

Isnard, Pierre, et al.. (2016). Karyomegalic Interstitial Nephritis. Medicine. 95(20). e3349–e3349. 28 indexed citations

10.

Karoui, Khalil El, Amandine Viau, Olivier Dellis, et al.. (2016). Endoplasmic reticulum stress drives proteinuria-induced kidney lesions via Lipocalin 2. Nature Communications. 7(1). 10330–10330. 101 indexed citations

11.

Mencarelli, Maria Antonietta, Laurence Heidet, Helen Storey, et al.. (2015). Evidence of digenic inheritance in Alport syndrome. Journal of Medical Genetics. 52(3). 163–174. 107 indexed citations

12.

Ong, Albert, Olivier Devuyst, Bertrand Knebelmann, & Gerd Walz. (2015). Autosomal dominant polycystic kidney disease: the changing face of clinical management. The Lancet. 385(9981). 1993–2002. 192 indexed citations

13.

Cohen, Camille, Bruno Royer, Vincent Javaugue, et al.. (2015). Bortezomib produces high hematological response rates with prolonged renal survival in monoclonal immunoglobulin deposition disease. Kidney International. 88(5). 1135–1143. 79 indexed citations

14.

Daudon, Michel & Bertrand Knebelmann. (2011). [Calcium oxalate urolithiasis].. PubMed. 61(3). 385–8. 1 indexed citations

15.

Bollée, Guillaume, Lucile Boutaud, Delphine Guillemot, et al.. (2010). Phenotype and Genotype Characterization of Adenine Phosphoribosyltransferase Deficiency. Journal of the American Society of Nephrology. 21(4). 679–688. 89 indexed citations

16.

Canaud, Guillaume, Bertrand Knebelmann, Peter C. Harris, et al.. (2010). Therapeutic mTOR Inhibition in Autosomal Dominant Polycystic Kidney Disease: What Is the Appropriate Serum Level?. American Journal of Transplantation. 10(7). 1710–1715. 56 indexed citations

17.

Camous, Laurent, Catherine Melander, Marion Vallet, et al.. (2008). Complete Remission of Lupus Nephritis With Rituximab and Steroids for Induction and Rituximab Alone for Maintenance Therapy. American Journal of Kidney Diseases. 52(2). 346–352. 26 indexed citations

18.

Bekri, Soumeya, Olivier Lidove, R. Jaussaud, Bertrand Knebelmann, & Frédéric Barbey. (2006). The Role of Ceramide Trihexoside (Globotriaosylceramide) in the Diagnosis and Follow-Up of the Efficacy of Treatment of Fabry Disease: A Review of the Literature. Cardiovascular & Hematological Agents in Medicinal Chemistry. 4(4). 289–297. 44 indexed citations

19.

Burel, Agnès, et al.. (2006). Role of HOXA7 to HOXA13 and PBX1 genes in various forms of MRKH syndrome (congenital absence of uterus and vagina). Journal of Negative Results in BioMedicine. 5(1). 4–4. 61 indexed citations

20.

Antignac, Corinne, Bertrand Knebelmann, Laurent Drouot, et al.. (1994). Deletions in the COL4A5 collagen gene in X-linked Alport syndrome. Characterization of the pathological transcripts in nonrenal cells and correlation with disease expression.. Journal of Clinical Investigation. 93(3). 1195–1207. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact